Glucose Homeostasis, Diabetes Mellitus, and Gender-Affirming Treatment
The transgender (trans) population includes individuals with gender identities more fittingly aligned with the opposite sex or with an alternative that transcends the classical dipole of male/female. Hormonal treatment in transgender individuals aims to suppress the secretion of endogenous sex stero...
Main Authors: | Charalampos Milionis, Ioannis Ilias, Evangelia Venaki, Eftychia Koukkou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/3/670 |
Similar Items
-
Is erectile dysfunction more prevalent from COVID-19’s beginning and onwards? What do relevant Google searches show?
by: Ioannis Ilias, et al.
Published: (2023-12-01) -
Localized Rhabdomyolysis Associated With Testosterone Enanthate for Gender-Affirming Hormonal Therapy
by: Rashmi Reddy, MD, et al.
Published: (2022-11-01) -
Maximizing surgical outcomes with gender affirming hormone therapy in gender affirmation surgery
by: Desha Gelles-Soto, et al.
Published: (2024-06-01) -
Two Transgender Men Receiving Subdermal Testosterone Pellets for Gender Affirmation
by: Sune L. Wolf Pulsiano, M3, et al.
Published: (2023-11-01) -
Impact of sex used for assignment of reference intervals in a population of patients taking gender-affirming hormones
by: Matthew D. Krasowski, et al.
Published: (2024-06-01)